MiraDx is an L.A.-based molecular diagnostics company founded by leading scientists and clinicians to advance the field of personalized genetic medicine. We are seeking an enthusiastic candidate who is willing to work in a highly collaborative and fast-pace environment. This candidate must actively hold a Clinical laboratory Scientist (CLS) license through California Department of Public Health (CDPH). A certification from ASCP and relevant clinical laboratory experience preferred however not required. He or she must independently perform various clinical laboratory procedures. Techniques required: DNA extraction, RNA extraction and RT-PCR.
The candidate shows good communication skills and multi-tasking skills. Must be flexible to the needs of the laboratory. This CLS will be responsible for but not limited to a variety of high-complexity, Molecular Diagnostic testing in a clinical laboratory setting. Perform QC/QA, preventative maintenance and test validation procedures for various reagents and instruments. Review and report test results in accordance with laboratory standards. Opportunities for growth and further training in areas of interest to the candidate. Maintain working knowledge of laboratory policies and procedures. Expected to collaborate and be able to complete assigned tasks in timely manner. Be able to troubleshoot common procedural relevant issues.
Bachelor’s Degree in Clinical Laboratory Sciences, Physical/Life Science or related.
Current California State license as a Clinical Laboratory Scientist, Generalist, or Molecular Specialist
ASCP certification preferred but not required
0-2 years of experience in a clinical laboratory setting.
Must have a positive attitude.
Ability to communicate effectively, follow written and verbal instructions.
Able to demonstrate time management skills.
Proficient in Microsoft office, including Microsoft Word and Excel.
Basic understanding of a LIS system.
About MiraDx, Inc.
MiraDx is an L.A.-based molecular diagnostics company founded by leading scientists and clinicians to advance the field of personalized genetic medicine. MiraDx partners with universities and pharmaceutical companies to utilize our unique genetic research to help better treat cancer. MiraDx was co-founded by Joanne Weidhaas, M.D., Ph.D. and Frank Slack, Ph.D. whose cutting-edge genetic research discovered this new class of genetic biomarkers. Our cutting-edge genetic research discovered a new class of genetic biomarkers that can dramatically change personalized treatment.